Advanced Therapies Europe 2020

29TH - 30TH SEPTEMBER 2020



Francesca Bellintani

Francesca Bellintani

Downstream Process Development Manager - Development Unit, MolMed S.p.A

Francesca Bellintani is a Downstream Process Development Manager at MolMed. Biologist by education she holds a degree in Biology from University of Milan working on overproduction and purification of recombinant proteins; she is specialised in Biochemistry working on Phage display in Cambridge University. With a demonstrated history of work in the biotechnology industry, she joined MolMed in 2007 and worked in the Development Unit with growing responsibilities, supervising a multidisciplinary team of scientists on projects from development to early phase GMP manufacturing. Francesca Bellintani has a strong operations expertise in the development of processes for the purification of proteins and retroviral/lentiviral vectors using chromatography and tangential flow filtration techniques.

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Jean-Philippe Combal
    GenSight Biologics
  • The conference consistently proves to be a great forum for networking with industry leaders in the development of cellular and gene therapies as well as vendors for important technologies and services.
    Michael Covington
    Juno Therapeutics, Inc
  • It was a very interesting event as all participants, including speakers were ready to exchange, even on the most challenging subjects such as reimbursement, GMP guidance
    Bertrand Alexandre
  • Phacilitate EU delivered it's promise and more, the topics discussed were highly relevant, with very good and professional speakers and panelists. You will see me next year in Berlin.
    Dr Ohad Karnieli
    Karnieli Ltd